Jair Bar, MD, PhD, Professor
Thoracic Oncologist | Deputy Director of Cancer Center | Lung Cancer Specialist
Areas of Expertise
Professor Jair Bar specializes in thoracic oncology, with a strong focus on advanced lung cancer treatment and translational research:
Lung Cancer (non-small cell and advanced stages)
Thoracic Oncology
Medical Oncology & Radiotherapy
Molecular Biology & Genetics in Cancer
Immunotherapy and Resistance Mechanisms
Translational Oncology Research
About the Doctor
Professor Jair Bar is a leading thoracic oncologist and serves as the Deputy Director of the Cancer Center at Sheba Medical Center.
He also heads the Thoracic Oncology Unit, where he focuses on the treatment of lung cancer using advanced systemic therapies, including immunotherapy and targeted treatments.
In addition to his clinical work, Prof. Bar leads a research laboratory dedicated to studying resistance to immunotherapy, contributing to the development of more effective cancer treatment strategies.
He combines clinical expertise with cutting-edge research, ensuring that patients benefit from the most up-to-date therapeutic approaches.
Clinical Approach
Personalized cancer treatment based on molecular and genetic profiling
Integration of immunotherapy, targeted therapy, and radiotherapy
Multidisciplinary decision-making for complex cases
Focus on improving survival outcomes and quality of life
Positions
Deputy Director, Cancer Center, Sheba Medical Center
Head of Thoracic Oncology Unit
Chair, Israel Lung Cancer Group (since 2003)
Senior Lecturer, Tel Aviv University
Professional Memberships
Member of Israel Society of Clinical Oncology and Radiotherapy
Member of American Society of Clinical Oncology
Member of American Association for Cancer Research
Education and Training
MD, Hebrew University of Jerusalem (Hadassah Medical School)
PhD in Molecular Biology, Weizmann Institute of Science
Board Certifications
Medical Oncology
Radiotherapy Oncology
Research & Publications
Professor Bar is actively involved in translational and clinical research, with publications focused on lung cancer biology and treatment, including:
Cancer metabolism in lung cancer based on exhaled breath analysis
Angiogenesis inhibition strategies in lung cancer therapy
He continues to contribute to advancing precision oncology and immunotherapy approaches in thoracic cancers.